HEALTHCARE

Market Highlights: The Global Myelodysplastic Syndrome (MDS) Drugs Market is expected to grow significantly over the forecast period. The Myelodysplastic Syndrome (MDS) drugs market held a valuation of USD 1,581.59 million in 2018 and is projected to register a CAGR of 10.1% over the forecast period. The increasing participation of key players is one of the key factors driving the  Myelodysplastic Syndrome (MDS) drugs  market. In 2018, the US Food and Drug Administration approved generic injectable product decitabine for Lupin Ltd. There are various other MDS medications available in the market. Various other factors that are driving the MDS drugs market are the promotion of clinical studies related to MDS, increasing geriatric population, rise in regulatory approvals, and growing participation of generic drugs manufactures. However, the risk of infections during blood transfusions and side-effects of chemotherapy may hamper market growth over the forecast pe...

Market Highlights: The global Opioid Withdrawal Treatment Market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Browse Full Report Details TOC Exclusively @  https://www.marketresearchfuture.com/reports/opioid-withdrawal-treatment-market-8123 Key Players: ·          Merck & Co ·          Teva Pharmaceutical Industries Ltd ...

Market Overview: The Global Cranial Fixation and Stabilization Market  is expected to reach  USD 2.29 Billion by 2025 , registering a CAGR of 8.90%. This market growth can be attributed to the growing healthcare market and the ever-expanding technology market. Advances in these fields have created an environment that is conducive to the development of specialized surgical procedures for traditionally high-risk surgeries. According to the UN, globally, one in six individuals suffers from a neurological disorder. There are several invasive surgeries that being developed to treat such conditions, requiring cranial fixation and stabilization equipment. Browse Full Report Details and TOC Details Exclusively  @  https://www.marketresearchfuture.com/reports/cranial-fixation-stabilization-market-8163 Key Players: Johnson & Johnson Stryker Ostomed KLS Martin Group Medtronic Integra LifeSciences Corporation Braun Melsungen AG Changzhou Hui...

Market Highlights: The   Global CAR T Cell Therapy Market  is expected to register a  CAGR of   58.52%  during the forecast period, with a market value of  USD 346.75 Million in 2018.  Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy used for cancer treatment. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. Growing prevalence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, and rise in the number of cell therapy clinical studies are driving the growth of the global CAR T Cell Therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018. Moreover, the growing pharmaceutical industry is also expected to boost market growth. ...